Hyperpigmentation, hyperkeratoses, and Bowen's disease are hallmarks of chronic arsenic exposure. The association between arsenic-induced skin lesions and subsequent internal cancers is examined by using a community-based prospective study. The cohort was enrolled from an arseniasis-endemic area in southwestern Taiwan, where 2,447 residents participated in skin examinations during the late 1980s. The number of participants diagnosed with hyperpigmentation was 673; with hyperkeratosis, 243; and with skin cancer (Bowen's disease or non-melanoma skin cancer), 378. Newly diagnosed internal cancers were ascertained through linkage with National Cancer Registry profiles. Cox regression was performed to estimate hazard ratios with 95% confidence intervals for potential risk predictors. Compared with participants without skin lesions, patients affected with skin cancers had a significantly increased risk of lung cancer (hazard ratio = 4.64, 95% confidence interval: 2.92, 7.38) and urothelial carcinoma (hazard ratio = 2.02, 95% confidence interval: 1.23, 3.30) after adjustment for potential confounders and cumulative arsenic exposure. Hyperkeratosis is significantly associated with an increased lung cancer risk (hazard ratio = 2.76, 95% confidence interval: 1.35, 5.67). A significant interactive effect on lung cancer risk between hyperkeratosis and cigarette smoking was identified, which suggests that patients with hyperkeratosis who have been exposed to arsenic should cease smoking.
A strong dose-response relationship between arsenic exposure and skin lesions has been consistently observed and, therefore, such lesions have been considered a biomarker of long-term exposure to arsenic (12) . However, even among people with a relatively high arsenic exposure for many years, less than 30% of exposed victims were affected with skin lesions in Bangladesh, India, and Taiwan (6, 13, 14) . It is possible that skin lesions may be biomarkers for susceptibility to arsenic-induced health effects. Several host factors, such as arsenic methylation capacity, genetic polymorphisms, and nutritional status, have been reported to modify the risk of skin lesions (15) (16) (17) .
The association of arsenical skin lesions with subsequent internal malignancies was systematically examined by Cuzick et al. (18) . A cohort of 478 patients who had been given Fowler's solution (potassium arsenite) for several weeks to 12 years were monitored for cancer mortality. No excess risk of internal malignancies was found among arsenic-exposed patients without palmar hyperkeratoses (18) . A later case-control study revealed a significant association between hyperkeratosis and lung/bladder cancer risk (19) . The association of previous skin signs with internal cancers was strengthened by the follow-up findings that all subsequent cancer deaths occurred in those with skin signs (20) . In a study in Japan, the residents in Nakajo were exposed to arsenic in well water for 5 years (21) . Markedly increased lung cancer mortality was observed among male and female residents with hyperpigmentation, hepatomegaly, or pancytopenia.
On the basis of these studies, researchers suggested that arsenical skin lesions might be predictors of subsequent internal malignancies, especially lung and bladder cancers. However, the above studies are limited by their small sample sizes, the lack of a comparable reference group, a lack of adjustment for possible confounding factors, and/or no exploration of interactions between skin lesions and other risk factors. Furthermore, the associations between various types of arsenical skin lesions and subsequent internal malignancies have never been compared. In this study, we examined the association between internal malignancies and various arsenical skin lesions in a community-based, 17-year follow-up study. In addition, the interactive effect on internal cancers between arsenical skin lesions and cigarette smoking was also examined.
MATERIALS AND METHODS

Blackfoot disease-endemic area
The present study cohort was recruited from 4 blackfoot disease-endemic townships (Peimen, Hsuechia, Putai, and Ichu) located on the southwestern coast of Taiwan. In this area, shallow well water (6-8 m deep) has high salinity, and most residents had used artesian well water (100-300 m deep) for >50 years from 1910 until the early 1970s, when a tap water reticulation system was implemented. In this area, the water from most deep wells had an arsenic concentration of 0.35-1.14 mg/L (median: 0.78 mg/L). The current maximum allowable arsenic contamination level for drinking water is 0.01 mg/L (Taiwan and the United States).
Study cohort and skin examination
The study cohort consisted of 3 separate subcohorts that were established between May 1985 and July 1989. The first subcohort included 257 blackfoot disease patients and 753 age-and sex-matched healthy community controls selected from 4 blackfoot disease-endemic townships (22) . Individuals less than 30 years of age at study entry, without complete personal identification information, with history of internal cancer at study entry, or without dermatological examination data were excluded (64 persons). The second subcohort included 1,571 study participants enrolled from 3 villages (Homei, Fuhsin, and Hsinming) in Putai Township in 1988 (23) . All the residents who were ≥30 years and had dwelled in the villages >5 days per week were enrolled. The prevalence of blackfoot disease in these 3 villages was highest across the blackfoot disease-endemic area. Community health examinations were held from 1989 to 1996. A total of 1,143 subjects had at least 1 skin examination. The third subcohort was recruited in 1989 and consisted of 245 patients affected with Bowen's disease or NMSC, including squamous cell carcinoma and basal cell carcinoma, together with 242 healthy controls matched on age, sex, and village. The same exclusion criteria were applied to subcohorts 2 and 3 as were applied to subcohort 1. The skin lesions of all participants in the 3 subcohorts were clinically diagnosed in the late 1980s by the same experienced dermatologists from Kaohsiung Medical University. Approximately 50% of the skin cancer diagnoses were evaluated by a pathologist.
During the recruitment process for the 3 subcohorts with skin examination data, 110 subjects were included in more than 1 subcohort and, thus, the full cohort consisted of 2,463 subjects. At baseline, within this cohort, 684 individuals had hyperpigmentation, 249 individuals had hyperkeratoses, and 314 individuals had skin cancer (Bowen's or NMSC). During follow-up, 75 new pathologically confirmed cases of skin cancer were reported to the National Cancer Registry Profile. Sixteen subjects with diagnosis and history of internal cancer before diagnosis of skin lesions/cancers or who had skin cancer diagnosed after 2005 were excluded. Finally, 2,447 subjects, including 673 individuals with hyperpigmentation, 243 individuals with hyperkeratoses (mostly palmoplantar), and 378 individuals with cancer (Bowen's (n = 262), squamous cell carcinoma (n = 43), basal cell carcinoma (n = 25), or both (33 mixed and 15 undefined)) were included in the analysis.
Questionnaire interview, arsenic exposure assessment, and cancer incidence follow-up All study participants were interviewed at home during the recruitment period by well-trained public health nurses using a structured questionnaire. The information obtained included sociodemographic characteristics, residential history, occupational history, lifestyle habits such as cigarette smoking ( past or current use, duration of use, starting age, and packs smoked per day), and history of well water consumption. The total number of years consuming artesian well water was estimated by a detailed history of water consumption including the duration and type of water sources used from birth to study entry. The lifetime cumulative arsenic exposure (CAE) from the artesian well water was defined as Σ(Ci × Di), where Ci was the median arsenic concentration in deep-well water of the village where the study subject lived during the period i, and Di was the duration of drinking the artesian water in the village during the same period i (23). The average arsenic concentration was estimated by dividing the CAE by total artesian well water consumption in years. The arsenic concentration in the wells was obtained from 2 investigations in which more than 38,565 wells from all over Taiwan were examined (24, 25) . The water samples were tested by the mercuric bromide stain method (26) .
Computerized linkage with the National Cancer Registry in Taiwan was used to identify newly diagnosed cancers across all participants. The Taiwan National Cancer Registry system was implemented in 1979. It is a complete, updated, and accurate nation-wide cancer registration system. For this study, we ascertained the incident cancer cases from study entry through December 31, 2006 .
Data analysis and statistical methods
In order to examine the association of internal cancer risk with the appearance of different types of skin lesions, we divided the cohort into 5 subgroups: Group 1, no arsenical Table continues 204 Hsu et al.
skin lesions; Group 2, hyperpigmentation only; Group 3, hyperkeratosis with or without hyperpigmentation; Group 4, skin cancer (Bowen's disease or NMSC) without hyperkeratosis, and Group 5, both skin cancer and hyperkeratosis. χ 2 tests were performed to test the statistical significance of the differences in distributions of selected characteristics among comparison groups. The internal cancer incidence of each group was calculated by dividing the number of cancer cases by the total number of follow-up person-years observed in a given group. Poisson regression analysis was used to test for the statistical significance of the differences in cancer incidence between Group 1 and each of Groups 2-5. For individuals with no history of skin lesions or cancer at the first skin examination who went on to be diagnosed with skin lesions or cancer at the next skin examination, the follow-up period before skin outcome diagnosis contributed person-time to the skin outcome-negative group, and the follow-up period after the lesion diagnosis contributed person-time to the skin outcome-positive group. As skin lesions could change during the follow-up period, Cox regression analysis with time-dependent covariates was used to determine the hazard ratios and 95% confidence intervals for developing internal malignancies. Stratified analyses of the association between skin lesions and risk of lung/urothelial carcinoma according to arsenic level were performed. CAE was grouped into <1.0, 1.0-19.9, and ≥20.0 mg/L × years. The average arsenic concentration was grouped into <0.100, 0.100-0.699, and ≥0.700 mg/L. Stratified analyses according to cigarette smoking (yes or no) and age at study entry (<60 or ≥60 years) were also performed. The statistical significance of the interactive effects on internal cancer risk between each type of skin lesion and cigarette smoking was assessed by using hierarchical likelihood testing. All analyses were performed by use of SAS, version 9.1.2, statistical software (SAS Institute, Inc., Cary, North Carolina). This study was approved by the Institutional Review Board of the National Taiwan University College of Public Health, and the informed consent of all participants was obtained.
RESULTS
Baseline characteristics for the 5 arsenical skin lesion groups are shown in Table 1 . Compared with the participants with no skin lesions, the participants with any skin lesion had a higher proportion of individuals who were older, were male, and had fewer years of schooling. The distribution of body mass index was similar among the groups. The percentage of cigarette smoking in males was lower in Groups 4 and 5 than in Groups 1-3. Participants affected by skin lesions included a higher proportion with a long period of well water consumption, with a high CAE and a high average arsenic concentration in their well water. The crude cancer incidence at various anatomical sites by skin group is shown in Table 2 . After an average of 14.2 years of follow-up, 439 internal cancers were diagnosed, including 59 liver cancers, 109 lung cancers, 113 urothelial carcinoma cases, and 9 prostate cancers. The association between arsenical skin lesions (Groups 2-4) and prostate cancer is the highest among the internal cancers examined, with an incidence from 10-to 20-fold greater than that in Group 1. Persons with skin cancer are 3 times as likely to develop internal cancers, with a double or greater crude incidence (≥4 cases) for stomach, intestinal, liver, and other gastrointestinal cancers; for lung cancers; for prostate cancers; and for urothelial carcinoma. Table 3 presents the hazard ratios for cancers of the stomach, intestines, liver, other gastrointestinal, lung, prostate, and urinary tract for Groups 2-5 individually and for Groups 4 and 5 combined, using Group 1 as the reference group. Only the groups with skin cancers with or without hyperkeratoses (Groups 4 and 5) have a significantly increased hazard Table 4 shows the multivariate analyses for lung cancers and urothelial carcinoma. It was found that skin cancers with or without hyperkeratosis (combined Groups 4 and 5) and hyperkeratosis (Group 3) were significant dermatological risk predictors for lung cancer. Only skin cancers (combined Groups 4 and 5) were significant dermatological risk predictors for urothelial carcinoma. Cigarette smoking was a significant risk predictor for lung cancer but not for urothelial carcinoma. There was a dose-response relationship between CAE and urothelial carcinoma risk after adjustment for dermatological factors, but the relationship was not present for lung cancer. The other arsenic exposure index models all show consistent findings (Web Table 1 , the first of 4 Web tables available at http://aje. oxfordjournals.org/), which finding supports an association between skin lesions and both cancers. Table 5 shows the multivariate-adjusted hazard ratios of developing lung cancer and urothelial carcinoma for arsenical skin lesions stratified by CAE. The hazard ratios for the association between hyperkeratoses and/or skin cancers (Groups 3-5) and lung cancer risk were greater for lowand moderate-level CAE participants than for high-level CAE participants. The association pattern of skin lesions with urothelial carcinoma risk did not show a consistent tendency with respect to arsenic levels. Table 6 demonstrates the multivariate-adjusted hazard ratio for the association of arsenical skin lesions with the risk of lung cancer and urothelial carcinoma stratified by cigarette smoking status. There was a strong interaction between cigarette smoking and hyperkeratosis with or without skin cancer (Groups 3 and 5) with respect to lung cancer (P interaction : 0.02-0.04). Smokers in Group 5 showed a strikingly higher lung cancer risk, a hazard ratio of 23.5 (95% CI: 9.4, 59.0), compared with nonsmokers with no lesions. No significant interaction between cigarette smoking and arsenical skin lesions was observed for urothelial carcinoma.
The similar magnitude of association between skin cancers with or without hyperkeratoses (combined Groups 4 and 5) and risk of lung cancer, as well as urothelial carcinoma, was observed among young and old participants (Web Tables 2 and 3 ). The association of hyperkeratosis with lung cancer seemed to be greater for younger people (age: <60 years). A sensitivity analysis that involved the Abbreviations: CI, confidence interval; HR, hazard ratio; NMSC, non-melanoma skin cancer.
*P < 0.05; **P < 0.01; ***P < 0.0001; P values are 2 sided.
a Age-and sex-adjusted hazard ratio. Arsenical Skin Lesions and Internal Cancers 207 removal of blackfoot disease patients showed a similar magnitude of association compared with the entire cohort (Web Table 4 ). This suggests that the association explained by these confounding factors was minimal.
DISCUSSION
We examined the association between arsenic-induced skin lesions and subsequent internal malignancies and assessed the interactions of skin lesions and cigarette smoking on cancer risk in this community-based, long-term followup study. The results showed that hyperkeratosis and skin cancers (Bowen's disease and NMSC) were significantly associated with increased lung cancer risk after adjustment for age, sex, body mass index, educational level, cigarette smoking, and various arsenic exposure indices. This could not be explained by potential confounding factors such as age/blackfoot disease status. Moreover, the stronger associations observed among participants with low or moderate arsenic exposure compared with high arsenic exposure indicate that arsenical skin lesions are susceptibility biomarkers for lung cancer risk. The association between skin cancer and subsequent lung cancer risk was observed regardless of cigarette smoking. Nonetheless, cigarette smoking intensified the association. On the other hand, hyperkeratosis among nonsmokers was not associated with excessive lung cancer risk, but a strong interaction was observed between hyperkeratosis and cigarette smoking. This suggests that hyperkeratoses and skin cancer are biomarkers for arsenic poisoning and may reflect biological damage in arsenicexposed lungs. Hyperpigmentation was not significantly associated with lung cancer, and there was no significant interaction between hyperpigmentation and cigarette smoking on lung cancer risk; hyperpigmentation did not seem to be a risk predictor for lung cancer.
Although Cuzick et al. (20) suggested an association between arsenical skin lesions and internal cancers that could not be readily explained by the strong association Abbreviations: CI, confidence interval; HR, hazard ratio; NMSC, non-melanoma skin cancer. * P < 0.05; **P < 0.01; ***P < 0.0001. a P values are 2 sided. b Group 1, no arsenical skin lesions; Group 2, hyperpigmentation only; Group 3, hyperkeratosis with or without hyperpigmentation; Group 4, skin cancer (Bowen's disease or NMSC) without hyperkeratosis; Group 5, both skin cancer and hyperkeratosis.
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between arsenic dose and skin lesions, previous studies have not carefully examined whether these skin lesions are able to predict subsequent internal malignancies independent of arsenic exposure level. In this study, we found significant associations between hyperkeratosis and/or skin cancers and lung cancer as well as between skin cancers and urothelial carcinoma after adjustment for the arsenical exposure level, indicating an independent role for these skin lesions in predicting subsequent internal malignancies. These findings suggest that arsenical skin lesions, especially hyperkeratosis and skin cancers, are not only biomarkers of long-term arsenic exposure, but also indicators of susceptibility to arsenic-induced health hazards. These skin lesions could be an aggregate marker that reflects arsenic methylation capabilities, nutrition status, DNA repair efficiency, and genetic susceptibility, all of which can modify the manifestation of arsenic-induced health effects (7, 15, 17, (27) (28) (29) . A dose-response trend for urothelial carcinoma risk relative to increasing arsenic levels after adjustment for skin lesions was detected, but no such biological gradient was observed for lung cancer. This suggests that the underlying mechanisms for arsenic-induced lung cancer and skin lesions may be similar. Careful evaluation of dermal conditions among arsenic-exposed people could be critical when identifying individuals at high risk of subsequent internal cancers, especially lung cancer.
It is important to note that participants with hyperkeratosis did not have an increased lung cancer risk unless they smoked cigarettes. Smokers with hyperkeratosis and/or skin cancer had a markedly high lung cancer incidence compared with smokers who did not have these skin lesions. This suggests that arsenic may be a cocarcinogen with other carcinogens including cigarette smoke, and this promotes lung carcinogenesis. Arsenic cocarcinogenicity and comutagenicity have been proposed previously (30) (31) (32) . Exposure to a low concentration level of arsenite may enhance mutagenicity by ultraviolet radiation, benzo(a)-pyrene diol epoxide, and alkylating agents. The arsenical cocarcinogenic mechanism of action has been suggested to include interference with DNA repair (33, 34) and inactivation of tumor suppressor protein p53 functioning (35, 36) . However, the precise mechanisms remain to be elucidated.
Our results showed that urothelial carcinoma had the highest incidence among all cancers in nonsmokers with or without arsenical dermatosis. On the basis of this observation, we suggest that the urinary tract is the organ most susceptible to arsenic in drinking water among nonsmokers. Only Bowen's disease or NMSCs are significant risk predictors for urothelial carcinoma after adjustment for long-term arsenic exposure. The association between hyperkeratosis and urothelial carcinoma was not significant in this study but was highly significant in a study from the United Kingdom (19) . The relatively high incidence of urothelial carcinoma (232 per 10 5 person-years) among the reference group in this study may explain this. Although the referent subjects had no arsenical skin lesions, more than 39% of subjects had a cumulative arsenic exposure higher than 1.0 mg/L × years (Table 1 ). Thus, urothelial carcinoma incidence among the reference group is much higher than that of the general population in Taiwan (17.5 per 10 5 for ages ≥30 years during 1991-2005). There is a great difference of exposure level among the referent subjects between these 2 studies, and that may be the reason for the inconsistent relationship between hyperkeratosis and urothelial carcinoma. A significant association between arsenical dermatosis and liver cancer was not observed. Nonetheless, a 67% increase in liver cancer risk was observed among subjects with skin cancers and hyperkeratoses, suggesting that a higher incidence of liver cancer should be expected among people with such skin signs. On the other hand, the association of arsenical skin lesions with prostate cancer, as well as other gastrointestinal cancers, was strikingly high, suggesting that arsenic has a carcinogenic role in the development of such cancers. However, this association needs further clarification because of the small case number and the lack of adjustments for major confounding factors.
There were several limitations to this study. First, no biological markers of arsenic exposure, such as urine or hair arsenic concentrations, are available, and arsenic levels in the artesian well water were estimated by using the median arsenic concentration of each village. Because arsenic levels within a village could be highly variable, potential exposure misclassification cannot be ruled out, and the dose-response relationship between exposure and disease outcomes may be underestimated. However, the influence could be relatively minor, because a large magnitude of disease risk was consistently observed among at-risk subjects with arsenical skin lesions after various arsenic exposure indices were considered. Second, the arsenic exposure occurred between 1910 and the 1970s, and the skin lesions were diagnosed in the late 1980s; it is likely that some skin lesions had disappeared several years after arsenic exposure ended, and these may have been ignored. Furthermore, there were no regular skin examinations after 1996, and some skin lesions that occurred later might have been missed. Misclassification of skin lesions may also have attenuated the association between the lesions and subsequent internal malignancies. Third, only 50% of clinically diagnosed Bowen's disease and NMSC patients had pathological confirmation. Misdiagnosis could not be ruled out for skin lesions without histological confirmation. However, the diagnosis was made by dermatologists who were experienced in arsenic-related studies, so the chance of misdiagnosis is minimal. This is the first community-based follow-up study to estimate the incidence rates and hazard ratios of internal malignancies according to arsenical dermatosis status. The results have important public health implications for millions of people who have been exposed to arsenic in drinking water worldwide. On the basis of our results, we suggest that the urinary tract is highly susceptible to arsenic-induced malignancy in nonsmokers. For cigarette smokers, a strikingly high lung cancer incidence was observed, especially for those affected with hyperkeratosis and/or skin cancers. We have also identified a significant association of Bowen's disease and NMSC with an increased lung, urinary tract, prostate, and other gastrointestinal cancer risk, but not with liver cancer. Hyperkeratoses by themselves are associated with increased lung cancer risk. The strong interaction between cigarette smoking and hyperkeratosis with or without skin cancer appeared to increase the risk of lung cancer significantly. Our study provides evidence that arsenic may act as a cocarcinogen that promotes lung carcinogenesis. It is urgently recommended that individuals at risk with arsenic-induced hyperkeratosis and/or skin cancer should stop smoking and avoid exposure to any other lung carcinogen.
